Cardiomyopathy: Disease of the heart muscle associated with cardiac dysfunction.
Classified based on structural and functional abnormalities.
Dilated Cardiomyopathy (DCM)
Most common form characterized by significant dilation of ventricles and systolic dysfunction.
Decreased ejection fraction and increased end-diastolic volume, leading to heart failure.
Hypertrophic Cardiomyopathy (HCM)
Characterized by increased heart muscle size, particularly along the septum.
Leading cause of sudden death in adolescents and young adults, especially athletes.
Restrictive (Constrictive) Cardiomyopathy (RCM)
Rigid ventricular walls resulting in impaired diastolic filling.
Symptoms similar to constrictive pericarditis.
Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D)
Inherited form characterized by replacement of myocardium with scar and adipose tissue.
Unclassified Cardiomyopathy
Displays features of multiple types and caused by conditions like fibroelastosis and mitochondrial diseases.
Impaired cardiac output leads to decreased stroke volume, activating sympathetic nervous system and the renin-angiotensin-aldosterone response.
Resulting in increased systemic vascular resistance and fluid retention, increasing workload on the heart.
Sodium is the major electrolyte involved; often leads to fluid overload and heart failure.
Diagnosis often through echocardiogram (decreased ejection fraction).
Distinguished by ventricular dilation without hypertrophy.
Leads to poor systolic function and high end-diastolic pressure, resulting in fluid overload and heart failure.
Over 75 possible conditions can cause DCM.
Idiopathic cases account for 20%-30% of nonischemic DCM cases.
Autosomal dominant inheritance.
Increased muscle size leads to ischemia due to restricted blood flow.
Annual ECG, physical exam, and echocardiograms advised for asymptomatic patients with positive genetic testing.
Possible obstruction of left ventricular outflow tract (LVOT). Symptoms include dyspnea, syncope, and arrhythmias.
Medical management through hydration, beta-blockers, or surgical options like myectomy or alcohol septal ablation.
Caused by rigid ventricular walls, leading to graduated increases in filling pressures and impaired diastolic function.
Symptoms similar to constrictive pericarditis, including dyspnea and chest pain.
May be either inherited or from systemic diseases. Diagnosis may require an endomyocardial biopsy.
Initially localized in the right ventricle; can progress to the left ventricle.
Symptoms may include palpitations, syncope, sudden cardiac death.
Diagnosis through ECG, echo, cardiac MRI, and family history. Genetic counseling recommended.
Characteristics are mixed from other types and relate to various underlying conditions.
Effective diagnosis involves patient history, echocardiography, and ruling out other heart conditions.
ECG findings may show arrhythmias and hypertrophy indicators.
Management includes identifying causes, correcting heart failure, and potentially implanted devices for arrhythmias.
Considered when heart failure progresses beyond medical treatment.
Challenges with donor availability and managing rejection versus infection.
Used for patients awaiting transplant or with advanced heart failure.
Increased use in destination therapy for patients ineligible for transplant.
Designed to replace both ventricles; complications include bleeding and infection.
Infective Endocarditis
Infection of heart valve endothelium, diagnosed by blood cultures and echocardiography. Symptoms include fever and heart murmur.
Myocarditis
Inflammation of myocardium; can result in dilation and heart failure. Symptoms may include flulike symptoms, fatigue, and dyspnea.
Pericarditis
Inflammation of the pericardium, symptoms include chest pain and can lead to effusion or cardiac tamponade.
Diagnosis often based on symptoms and echocardiography. Treatment includes IV antibiotics and may require surgical intervention for severe cases.